CA
ABBV icon

CGN Advisors’s AbbVie ABBV Stock Holding History

CGN Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$529K Buy
2,104
+73
+4% +$15.7K 0.04% 226
2026
Q1 		$442K Sell
2,031
-182
-8% -$40.4K 0.03% 234
2025
Q4 		$506K Buy
2,213
+37
+2% +$8.43K 0.04% 222
2025
Q3 		$504K Buy
2,176
+19
+0.9% +$3.87K 0.04% 215
2025
Q2 		$400K Buy
2,157
+112
+5% +$20.8K 0.04% 232
2025
Q1 		$428K Buy
2,045
+191
+10% +$37.1K 0.04% 225
2024
Q4 		$329K Hold
1,854
– – 0.03% 245
2024
Q3 		$366K Buy
1,854
+112
+6% +$20.9K 0.04% 228
2024
Q2 		$299K Sell
1,742
-59
-3% -$9.77K 0.03% 229
2024
Q1 		$328K Sell
1,801
-510
-22% -$87.9K 0.04% 212
2023
Q4 		$358K Sell
2,311
-2,874
-55% -$419K 0.05% 198
2023
Q3 		$773K Buy
5,185
+902
+21% +$132K 0.1% 160
2023
Q2 		$577K Buy
4,283
+94
+2% +$13.8K 0.08% 166
2023
Q1 		$668K Buy
4,189
+446
+12% +$68.2K 0.11% 155
2022
Q4 		$605K Sell
3,743
-50
-1% -$7.67K 0.11% 158
2022
Q3 		$509K Buy
3,793
+202
+6% +$29K 0.13% 163
2022
Q2 		$550K Hold
3,591
– – 0.16% 143
2022
Q1 		$582K Sell
3,591
-728
-17% -$106K 0.15% 136
2021
Q4 		$585K Buy
4,319
+2,436
+129% +$288K 0.15% 133
2021
Q3 		$203K Hold
1,883
– – 0.07% 195
2021
Q2 		$212K Hold
1,883
– – 0.07% 206
2021
Q1 		$204K Sell
1,883
-11
-0.6% -$1.18K 0.07% 193
2020
Q4 		$203K Buy
+1,894
New +$182K 0.08% 189

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CGN Advisors's ABBV Position: Q2 2026 in Review

CGN Advisors increased its AbbVie (ABBV) stake by 3.6% in Q2 2026, buying an estimated $15.7K and bringing the position to 2,104 shares worth $529K. The position accounts for 0.04% of the portfolio, ranked #226.

CGN Advisors first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. The position peaked at $773K in Q3 2023. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • CGN Advisors held 2,104 shares of AbbVie worth $529K as of Q2 2026.
  • CGN Advisors bought 73 AbbVie shares in Q2 2026, an estimated $15.7K.
  • AbbVie made up 0.04% of CGN Advisors's portfolio in Q2 2026, its #226 holding.
  • CGN Advisors first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • CGN Advisors's AbbVie position peaked at $773K in Q3 2023.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on CGN Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.